Search research articles
Contact Us
Filters
Showing results (261-270 of 352) with videos related to
Page
of 36
Sort By:
The New England Journal of Medicine
|
April 16, 2010
Infliximab, azathioprine, or combination therapy for Crohn's disease
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, et al.
United European Gastroenterology Journal
|
October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Inflammatory Bowel Diseases
|
December 10, 2024
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study
Hiroshi Nakase, Silvio Danese, Walter Reinisch, et al.
Journal of Crohn'S & Colitis
|
January 31, 2016
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs
Krisztina B Gecse, Shaji Sebastian, Gert de Hertogh, et al.
Zeitschrift Fur Gastroenterologie
|
March 13, 2018
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases]
Wolfgang Miehsler, Clemens Dejaco, Hans-Peter Gröchenig, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Inflammatory Bowel Diseases
|
February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Page
of 36
Search research articles
Search
Showing results (261-270 of 352) with videos related to
Sort By:
Page
of 36
The New England Journal of Medicine
|
April 16, 2010
Infliximab, azathioprine, or combination therapy for Crohn's disease
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, et al.
United European Gastroenterology Journal
|
October 11, 2024
Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework
Paula Leão Moreira, Axel Dignass, Maria Manuela Estevinho, et al.
Inflammatory Bowel Diseases
|
December 10, 2024
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study
Hiroshi Nakase, Silvio Danese, Walter Reinisch, et al.
Journal of Crohn'S & Colitis
|
January 31, 2016
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs
Krisztina B Gecse, Shaji Sebastian, Gert de Hertogh, et al.
Zeitschrift Fur Gastroenterologie
|
March 13, 2018
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases]
Wolfgang Miehsler, Clemens Dejaco, Hans-Peter Gröchenig, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Gastroenterology
|
November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis
William J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Journal of Crohn'S & Colitis
|
March 24, 2017
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
Maria Rosario, Jonathan L French, Nathanael L Dirks, et al.
Inflammatory Bowel Diseases
|
February 28, 2020
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study
Walter Reinisch, Remo Panaccione, Peter Bossuyt, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Page
of 36